Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2023-06-08 Delisting Announcement
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Delisting Announcement Classification · 99% confidence The document is a press release from Mauna Kea Technologies announcing the planned transfer of its stock listing from Euronext Paris (regulated market) to Euronext Growth Paris. This announcement details the shareholder approval, the rationale for the move (lighter regulatory framework, cost reduction), and a provisional timeline for the transfer. This type of corporate action announcement, which concerns the structure of its listing and regulatory environment, does not fit neatly into standard periodic reports (10-K, IR, ER) or specific transactional reports (DIV, DIRS, CAP). Since it is a formal announcement regarding a significant corporate event related to its listing status and regulatory compliance, and it doesn't perfectly match the definitions for Capital/Financing Update (CAP) or Delisting (DLST) (as it's a transfer, not a pure delisting), the most appropriate general category for a significant, non-standard regulatory/corporate action announcement is 'Regulatory Filings' (RNS), which serves as a broad category for such official notices that don't fit elsewhere. However, given the focus on capital structure and listing rules, 'Capital/Financing Update' (CAP) is also a possibility, but the core subject is the *listing venue change* itself. Since the document is a detailed announcement of a corporate action affecting its listing, and it is not a report itself (it announces the publication of a 'Document d'information relatif au transfert'), RNS is the best fit as a general regulatory announcement fallback, although it is a very specific type of corporate action announcement. Given the options, and recognizing this is a formal announcement of a change in listing venue and associated regulatory implications, RNS is the most suitable catch-all for significant, non-periodic corporate news.
2023-06-08 French
Inside Information / Other news releases
AGM Information Classification · 99% confidence The document title explicitly states: "Mauna Kea Technologies Announces Results of its 2023 Ordinary and Extraordinary Annual General Meeting". The text confirms that the shareholders adopted resolutions during the AGM, including financial statements and compensation policies. This content directly relates to the proceedings and outcomes of an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (4360 chars) is substantial enough to be the announcement itself, not just a brief RPA.
2023-06-05 English
Informations privilégiées / Autres communiqués
AGM Information Classification · 98% confidence The document is titled "Mauna Kea Technologies annonce les résultats de son Assemblée générale mixte du 2 juin 2023" (Mauna Kea Technologies announces the results of its Combined General Meeting of June 2, 2023). It explicitly discusses the adoption of resolutions presented at the Annual General Meeting (AGM), including the approval of annual accounts and remuneration policies. This content directly relates to the proceedings and outcomes of the AGM. Therefore, the most appropriate classification is AGM Information (AGM-R). Although it mentions voting results, the primary focus is the announcement of the meeting's outcome and key approvals, which aligns best with AGM-R rather than DVA (Declaration of Voting Results & Voting Rights Announcements), which is usually a more specific report of the vote tally itself. Given the context of announcing the results of the 'Assemblée générale mixte' (Combined General Meeting), AGM-R is the best fit.
2023-06-05 French
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release dated June 1st, 2023, announcing the start of enrollment in a multi-site clinical trial. It details the study's objectives, methodology (combining Cellvizio and Ion platforms), and includes quotes from the CEO and standard company/disclaimer sections. This type of announcement, focusing on operational progress, clinical studies, and strategic developments, is typically classified as a general Regulatory Filing (RNS) or sometimes an Investor Presentation (IP) if it were a slide deck. However, since it is a news announcement about a clinical trial update and not a formal financial report (like 10-K, IR, ER, or MDA), and it doesn't fit the specific categories like DIRS, DIV, or CAP, the most appropriate general category for significant operational news that isn't a core financial report is Regulatory Filings (RNS), which serves as a broad category for official company announcements not covered elsewhere. Given the content is a news release about a clinical trial, RNS is the best fit among the provided options for a non-financial, operational update.
2023-06-01 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from Mauna Kea Technologies dated June 1, 2023, announcing the recruitment of the first patient in a multicenter clinical trial combining their Cellvizio product with Intuitive Surgical's Ion platform for lung cancer. This type of announcement, detailing operational progress, clinical trial initiation, and strategic partnerships, is characteristic of a general corporate update or news release. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general announcement about company activity that doesn't fit the highly specific categories (like DIRS, DIV, CAP, etc.), the most appropriate classification is the general regulatory announcement/miscellaneous category, RNS, as per the provided definitions, although it functions as a press release.
2023-06-01 French
Inside Information / Other news releases
Capital/Financing Update Classification · 99% confidence The document is a press release dated May 31, 2023, announcing that Mauna Kea Technologies has secured an equity line financing agreement with Vester Finance. This involves the potential issuance of new shares, which directly relates to the company's capital structure and fundraising activities. This fits the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). Since it is a specific announcement about securing financing and capital structure changes, CAP is the most appropriate classification.
2023-05-31 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.